Beloorbayir Biotech Profile
Key Indicators
- Authorised Capital ₹ 67.00 Cr
- Paid Up Capital ₹ 39.94 Cr
- Company Age 19 Year, 11 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 55.44 Cr
- Satisfied Charges ₹ 51.27 Cr
- Revenue Growth -18.40%
- Profit Growth 129.80%
- Ebitda -3.50%
- Net Worth 0.09%
- Total Assets -0.01%
About Beloorbayir Biotech
Beloorbayir Biotech Limited (BBL) is a leading Public Limited Indian Non-Government Company incorporated in India on 02 March 2005 and has a history of 19 years and 11 months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 67.00 Cr and a paid-up capital of Rs 39.94 Cr.
The company currently has active open charges totaling ₹55.44 Cr. The company has closed loans amounting to ₹51.27 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Beloorbayir Biotech Limited India is Vasantkumar Hegde as CFO. Ashok Sinha, Ajay Bairy, Beloor Bairy, and Two other members serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100KA2005PLC035741
- Company No.
035741
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
02 Mar 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Beloorbayir Biotech?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Beloor Bairy ![]() | Managing Director | 02-Mar-2005 | Current |
Vasantkumar Hegde | CFO | 14-May-2020 | Current |
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ashok Sinha ![]() | Director | 28-Mar-2015 | Current |
Arvind Raghavan ![]() | Director | 28-Mar-2015 | Current |
Ajay Bairy ![]() | Whole-Time Director | 02-Mar-2005 | Current |
Veena Bairy ![]() | Director | 02-Mar-2005 | Current |
Financial Performance of Beloorbayir Biotech.
Beloorbayir Biotech Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 18.4% decrease. The company also saw a substantial improvement in profitability, with a 129.8% increase in profit. The company's net worth moved up by a moderate rise of 0.09%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Beloorbayir Biotech?
In 2020, Beloorbayir Biotech had a promoter holding of 54.92% and a public holding of 45.08%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹55.44 Cr
₹51.27 Cr
Charges Breakdown by Lending Institutions
- Others : 42.44 Cr
- Hdfc Bank Limited : 13.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
28 Nov 2016 | Hdfc Bank Limited | ₹3.00 Cr | Open |
21 Mar 2016 | Hdfc Bank Limited | ₹10.00 Cr | Open |
04 Jul 2014 | Others | ₹42.44 Cr | Open |
26 Jul 2010 | Idbi Bank Limited | ₹27.78 Cr | Satisfied |
21 Mar 2005 | Indianoverseasbank | ₹23.49 Cr | Satisfied |
How Many Employees Work at Beloorbayir Biotech?
Beloorbayir Biotech has a workforce of 110 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Beloorbayir Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Beloorbayir Biotech's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.